{"id":1302,"date":"2025-12-04T16:55:23","date_gmt":"2025-12-04T16:55:23","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/?p=1302"},"modified":"2025-12-04T16:55:23","modified_gmt":"2025-12-04T16:55:23","slug":"balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/","title":{"rendered":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing"},"content":{"rendered":"

The announcement of a new UK-US pharmaceuticals deal<\/a>\u00a0is an important change in the UK\u2019s approach to how new medicines are evaluated, priced and adopted. Faster access to innovative treatments for conditions such as cancer will be welcomed by patients and professionals. The increased investment in medicines may also help the UK attract more clinical research.<\/p>\n

However, the impact of the proposals will depend on implementation. Raising NICE\u2019s cost-effectiveness thresholds will increase overall NHS spending on medicines. Without a corresponding investment in areas such as workforce, diagnostics and primary care, there is a risk that higher drug spending could divert resources from other parts of the NHS. A more flexible pricing environment could also reduce the UK\u2019s future negotiating leverage with industry. Maintaining NICE\u2019s independence will be essential to maintain both public and professional confidence in its decision-making.<\/p>\n

The changes have could benefit patients and strengthen the UK\u2019s life sciences sector. But they will require careful monitoring to ensure that the promised improvements in access, equity, and health outcomes are realised; whilst also managing the financial challenges for an already pressured NHS.<\/p>\n","protected":false},"excerpt":{"rendered":"

The announcement of a new UK-US pharmaceuticals deal\u00a0is an important change in the UK\u2019s approach to how new medicines are evaluated, priced and adopted. Faster access to innovative treatments for conditions such as cancer will be welcomed by patients and professionals. The increased investment in medicines may also help the UK attract more clinical research. […]<\/p>\n","protected":false},"author":1115,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[308111],"tags":[250954],"class_list":["post-1302","post","type-post","status-publish","format-standard","hentry","category-nhs","tag-prescribing"],"yoast_head":"\nBalancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre\" \/>\n<meta property=\"og:description\" content=\"The announcement of a new UK-US pharmaceuticals deal\u00a0is an important change in the UK\u2019s approach to how new medicines are evaluated, priced and adopted. Faster access to innovative treatments for conditions such as cancer will be welcomed by patients and professionals. The increased investment in medicines may also help the UK attract more clinical research. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Centre\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T16:55:23+00:00\" \/>\n<meta name=\"author\" content=\"Azeem Majeed\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Azeem Majeed\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/\"},\"author\":{\"name\":\"Azeem Majeed\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/#\\\/schema\\\/person\\\/b22e0e53db849fda7de9e32c14d3df25\"},\"headline\":\"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing\",\"datePublished\":\"2025-12-04T16:55:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/\"},\"wordCount\":198,\"keywords\":[\"Prescribing\"],\"articleSection\":[\"NHS\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/\",\"name\":\"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/#website\"},\"datePublished\":\"2025-12-04T16:55:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/#\\\/schema\\\/person\\\/b22e0e53db849fda7de9e32c14d3df25\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/2025\\\/12\\\/04\\\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/#website\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/\",\"name\":\"Medical Centre\",\"description\":\"Updates from Imperial College London's Professor of Primary Care\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/#\\\/schema\\\/person\\\/b22e0e53db849fda7de9e32c14d3df25\",\"name\":\"Azeem Majeed\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g\",\"caption\":\"Azeem Majeed\"},\"description\":\"I am Professor of Primary Care and Public Health, and Head of the Department of Primary Care & Public Health at Imperial College London. I am also involved in postgraduate education and training in both general practice and public health, and I am the Course Director of the Imperial College Master of Public Health (MPH) programme.\",\"sameAs\":[\"http:\\\/\\\/www.imperial.ac.uk\\\/people\\\/a.majeed\"],\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/medical-centre\\\/author\\\/amajeed\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/","og_locale":"en_GB","og_type":"article","og_title":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre","og_description":"The announcement of a new UK-US pharmaceuticals deal\u00a0is an important change in the UK\u2019s approach to how new medicines are evaluated, priced and adopted. Faster access to innovative treatments for conditions such as cancer will be welcomed by patients and professionals. The increased investment in medicines may also help the UK attract more clinical research. […]","og_url":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/","og_site_name":"Medical Centre","article_published_time":"2025-12-04T16:55:23+00:00","author":"Azeem Majeed","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Azeem Majeed","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/#article","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/"},"author":{"name":"Azeem Majeed","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/#\/schema\/person\/b22e0e53db849fda7de9e32c14d3df25"},"headline":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing","datePublished":"2025-12-04T16:55:23+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/"},"wordCount":198,"keywords":["Prescribing"],"articleSection":["NHS"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/","url":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/","name":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing - Medical Centre","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/#website"},"datePublished":"2025-12-04T16:55:23+00:00","author":{"@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/#\/schema\/person\/b22e0e53db849fda7de9e32c14d3df25"},"breadcrumb":{"@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/2025\/12\/04\/balancing-innovation-and-affordability-the-new-uk-approach-to-drug-pricing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/"},{"@type":"ListItem","position":2,"name":"Balancing Innovation and Affordability: The New UK Approach to Drug Pricing"}]},{"@type":"WebSite","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/#website","url":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/","name":"Medical Centre","description":"Updates from Imperial College London's Professor of Primary Care","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/#\/schema\/person\/b22e0e53db849fda7de9e32c14d3df25","name":"Azeem Majeed","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d2985c036ad0b1b454e88876b26c4c477be22a2218f7b5ce5e589d35efd30d78?s=96&d=mm&r=g","caption":"Azeem Majeed"},"description":"I am Professor of Primary Care and Public Health, and Head of the Department of Primary Care & Public Health at Imperial College London. I am also involved in postgraduate education and training in both general practice and public health, and I am the Course Director of the Imperial College Master of Public Health (MPH) programme.","sameAs":["http:\/\/www.imperial.ac.uk\/people\/a.majeed"],"url":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/author\/amajeed\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/posts\/1302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/users\/1115"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/comments?post=1302"}],"version-history":[{"count":1,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/posts\/1302\/revisions"}],"predecessor-version":[{"id":1303,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/posts\/1302\/revisions\/1303"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/media?parent=1302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/categories?post=1302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/medical-centre\/wp-json\/wp\/v2\/tags?post=1302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}